Press Releases
 
New Report Examines the Neurosurgery Drugs Market Research

, 12 January 2018 -- Neurosurgery Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Neurosurgery is a surgical specialty concerned with the treatment of disorders and diseases related to the spinal cord, sympathetic and peripheral nervous system, and brain. Medications related to neurosurgical conditions include four drugs: Phenytek, Phenytoin Sodium, Dilantin, and Phenytoin. These are anti-epileptic drug or anticonvulsant. Epilepsy causes recurrent seizures that are unprovoked by neurologic insults or acute systemic. Phenytoin is used to control these seizures by slowing down brain impulses caused by this disorder. Seizures can occur due to bleeding in the brain caused by injuries, brain tumors, or brain surgery. Phenytoin sodium is included under the drug class Hydantoins. Phenytoin is a hydantoin derivative anticonvulsant drug. Phenytoin sodium is used to reduce neuropathic pain, cardiac glycoside intoxication, cardiac arrhythmias, status epilepticus, seizures associated with neurosurgery, absence (petit mal) seizures, partial seizures, and tonic-clonic seizures.

Long-term side effects of cerebellar ataxia and osteopenia, reduce their use by neurologists. Neurosurgery drugs have narrow therapeutic index and zero-order kinetics that makes these drugs to be one of the most difficult antiepileptic drugs to use. Moreover, these drugs are likely to have significant bidirectional drug interactions. Some neurosurgery drugs may cause difficulty in coordinating movements, confusion, headaches, nausea, dizziness, and drowsiness. If these drugs are ingested during pregnancy, they can causing various abnormalities in the baby.

The neurosurgery drugs market is driven by the rise in geriatric population with neurological disorders. The Global Campaign against Epilepsy sponsored by the International League against Epilepsy, the International Bureau for Epilepsy, and the World Health Organization advocates using phenobarbital to increase health promotions in low-income countries. This projected to boost the neurosurgery drugs market. According to the book Neurological Disorders, written by Rajesh Pandav, Ramanan Laxminarayan, Vijay Chandra, and others, states that a study conducted in developed countries on people who underwent epilepsy surgery indicated that 58% of them are seizure free, while 10% to 15% people have less frequent seizures, and even if the patients have less or no seizures, medications need to be continued for one to two years.

This is projected to support the expansion of the neurosurgery drugs market. Statistics from the World Health Organization suggests that the global burden of neurological diseases was approximately 92 million disability-adjusted life years (DALYs) in 2005 and is estimated to reach 103 million DALYs by the end of 2030. Rapidly increasing burden of neurological diseases is likely to increase the number of neurological surgeries, thereby increasing the demand for neurosurgery drugs.

The neurosurgery drugs market can be segmented based on drug class, disease type, distribution channel, and region. In terms of drug class, the market can be categorized into hydantion anticonvulsants, and group I antiarrhythmics. Based on disease type, the neurosurgery drugs market can be classified into neuropathic pain, cardiac glycoside intoxication, cardiac arrhythmias, status epilepticus, seizures associated with neurosurgery, absence (petit mal) seizures, partial seizures, and tonic-clonic seizures. In terms of the distribution channel, the market can be segmented into retail pharmacies, hospital pharmacies, and online pharmacies.

Based on geography, the neurosurgery drugs market can be divided into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America accounted for a large share of the market in 2016 owing to the increasing geriatric population and rise in research & development activities. Europe held the second large share of the market in 2016, due to rising stress levels and increasing inclination toward drug addiction for pain relief, which are expected to boost the demand for neurosurgery drugs. The market in Asia Pacific is anticipated to expand at a moderate pace during the forecast period owing to technological advancements and increasing stress levels in developed and developing countries. The market in Middle East & Africa and Latin America is projected to expand during the forecast period due to increasing health promotions in these countries.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37808

Key players operating in the neurosurgery drugs market are Pfizer Inc., Sun Pharmaceutical Industries Limited, WOCKHARDT, and Mylan N.V.

# # #


Submitted by Sandy Researcher, Transparency Market Research on Friday, 12 January 2018 at 6:33 PM
Category: Health Care & Medical
 
Related News

Root Canal Obturator Market Scope and Opportunities Analysis 2017 - 2025
Tuesday, 24 Apr 2018

DNA Polymerase Market Latest Trends and Future Growth Study by 2025
Tuesday, 24 Apr 2018

Gas Chromatography Systems Market Share and Growth Factors Impact Analysis 2017 - 2025
Tuesday, 24 Apr 2018

Additive Manufacturing Technologies Market Competitive Landscape Analysis with Forecast by 2025
Tuesday, 24 Apr 2018

Foley Catheter Market Current Trends and Future Aspect Analysis 2017 - 2025
Tuesday, 24 Apr 2018

Related Events

RNASeq Summit
Tuesday, 24 Apr 2018

European Neoantigen Summit
Tuesday, 24 Apr 2018

Antigen- Specific Immune Tolerance Drug Development Summit
Tuesday, 24 Apr 2018

2018 eRegulatory Summit, Lisbon
Tuesday, 24 Apr 2018

Work 2.0
Tuesday, 24 Apr 2018

Latest News

The Fast Crime Scene Cleanup Services
Wednesday, 25 Apr 2018

Daily Comex Report of 25 April 2018 by Epic Research
Wednesday, 25 Apr 2018

Jeffree Star Plastic Surgery Before and After – Most Vital Tips
Wednesday, 25 Apr 2018

Hurry to Buy RS 3 Gold with 6% off&Double Points for T92 dyes Until May.2
Wednesday, 25 Apr 2018

Labor Day Promo:OSRS Gold with 6% off&Double Points for Bryophyta Until May.2
Wednesday, 25 Apr 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Wednesday, 25 April 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Argus Marpol Strategy Summit
  • European Neoantigen Summit
  • Oil & Gas Supply Chain Compliance 2018
  • 2018 eRegulatory Summit, Lisbon
  • Antigen- Specific Immune Tolerance Drug Development Summit

  • Latest Jobs
    Sorry, there are currently no entries posted here.